Treatments for uremic bleeding target the various factors that seem to have a role in platelet dysfunction. Interventions can exert acute (within 6 h) or delayed (within several weeks) effects ...
It has been known for many decades that uremic bleeding and platelet dysfunction put patients at increased risk of general bleeding. The exact mechanism by which the risk is increased remains ...
Hemolytic uremic syndrome is a devastating, life-threatening thrombotic microangiopathy characterized by the triad of thrombocytopenia, microangiopathic hemolytic anemia, and renal failure. The ...
Atypical hemolytic uremic syndrome is an ultra-rare genetic disease that causes anemia and damages kidney function. There is an approved treatment — a therapeutic antibody called eculizumab ...